linkedin post 2013-03-05 16:24:24

THE NOVARTIS CEO WANTS TO REINVENT THE BROKEN BIG PHARMA BUSINESS MODEL. Faced with the easy pickings having been made, patent expiries, new reimbursement gatekeepers, and patient-centric care, the old ways of doing business is now at an end for Big Pharma. Fortunately, there are many options. As Takeda is already proving, by outsourcing R&D to small, creative companies that are only good at invention, and have neither the desire, muscle, nor expertise to do the selling. Those unwilling or unable to change will likely be consumed as the world changes about them.

http://lnkd.in/YCa7RF

View in LinkedIn